ClinicalTrials.Veeva

Menu

Study Project Comparing the Sequelae of COVID-19 Infection in Patients Who Have and Have Not Received Ventilatory Support in Critical Care (COMEBAC)

A

Assistance Publique - Hôpitaux de Paris

Status

Completed

Conditions

Covid19

Study type

Observational

Funder types

Other

Identifiers

NCT04704388
COMEBAC

Details and patient eligibility

About

To assess the proportion of post-intensive care syndrome (PICS) of patients who received high flow humidified oxygen with FiO2 ≥50% for more than 48h and / or who received mechanical ventilation for more than 48h in a context of hospitalization in intensive care for COVID-19 pneumonia

Enrollment

478 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Group 1: patients hospitalized in intensive care units for ARDS with SARS-CoV-2

  • Major
  • Admitted between March 1 and May 10, 2020 in one of the sectors of the Bicêtre hospital approved for critical care
  • proven SARS-CoV-2 infection
  • Treated by invasive mechanical ventilation or high flow humidified oxygen with FiO2 ≥50% for more than 48 hours.

Group 2: patients hospitalized outside intensive care units

  • Major
  • Admitted between March 1 and May 10, 2020 in an area of Bicêtre hospital having cared for patients infected with SARS-CoV-2 excluding critical care: pulmonology, internal medicine / orthopedics, infectious diseases, nephrology , acute geriatrics, neurology.

Exclusion criteria

  • Patients having refused the post consultation at 3 month
  • Without social security coverage

Trial design

478 participants in 2 patient groups

patients hospitalized in intensive care units for SARS-CoV-2
Description:
patients hospitalized in intensive care units for SARS-CoV-2
patients hospitalized outside intensive care units
Description:
patients hospitalized outside intensive care units

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems